Sort
30,917 grants matching “tumor microenvironment”
PSGL-1, a New Player in the Immune Checkpoint Landscape
$254,475Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2017 · CA
Role of Follicular Dendritic Cells in B lymphoma
$254,475Robert C Rickert · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2016 · CA
Role of tRXRalpha in pancreatic cancer development and therapy
$254,475Xiao-Kun Zhang · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2013 · CA
Characterization and suppression of resistance to NEDD8 E1 inhibition
$254,475Matthew Petroski · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2014 · CA
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
$254,475Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2017 · CA
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis
$254,472James V Degregori · University Of Colorado Denver · R01 · FY2021 · AG
Comparative Functional Genomics
$254,396Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A2a receptor engagement promotes T cell tolerance
$254,392Jonathan D Powell · Johns Hopkins University · R01 · FY2010 · CA
A2a receptor engagement promotes T cell tolerance
$254,392Jonathan D Powell · Johns Hopkins University · R01 · FY2007 · CA
A2a receptor engagement promotes T cell tolerance
$254,392Jonathan D Powell · Johns Hopkins University · R01 · FY2008 · CA
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
$254,250Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Contextual Glioblastoma Screening For Efficacious Radiation Sensitizers
$254,250Dimitris G. Placantonakis · New York University School Of Medicine · R21 · FY2014 · NS
Tracking the in vivo proliferative history of human glioma-derived stem cells
$254,250Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R21 · FY2013 · NS
A New Anti-CD27 Monoclonal Antibody Adjuvant for Pancreatic Cancer Vaccines
$254,250Sarah Jane Schlesinger · Rockefeller University · R21 · FY2013 · AI
Ras-mediated signals in human epithelial cell transformation and metastasis
$254,220Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Role of Tumor in Therapeutic Response and Resistance
$254,210Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
IMMUNOTHERAPY WITH CAR T CELLS
$254,176Carl H. June · University Of Pennsylvania · R01 · FY2013 · CA
Normal and UV-Induced cutaneous antigen presenting cells
$253,876Kevin D Cooper · Case Western Reserve University · R01 · FY2007 · AI
In situ anti-tumor immunity and effects of radiation
$253,781Edith M. Lord · University Of Rochester · R01 · FY2006 · CA
Project 3: Circumventing extracellular Adenosine barrier to oncolytic virotherapy
$253,752Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2024 · CA
New tools for imaging and theranostics in inflammation and cancer
$253,741Sangeeta Ray · Ut Southwestern Medical Center · P41 · FY2025 · EB
Tumor Progression and Metastasis
$253,734Jeffrey W. Pollard · Albert Einstein College Of Medicine · P01 · FY2011 · CA
Targeting IL-6/IL-6R/STAT3 in EMDR in Neuroblastoma
$253,723Yves A Declerck · Children'S Hospital Of Los Angeles · U54 · FY2012 · CA
Novel Immunomodulation and Facilitation of âSuppression Proofâ CAR NK cell against Ewing sarcoma
$253,700Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2023 · CA
Project 4:Targeting M2-like Macrophages and MDSC with Myelolytic-Virotherapy
$253,700Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2023 · CA